Therefore, GPR was a better biomarker to identify advanced fibrosis (F3-4) and non-advanced fibrosis (F1-2) in patients with chronic hepatitis B(Table 4; Fig. 3). The gene discussed is ALDH18A1; the disease is chronic hepatitis B virus infection.